OSD
Showing 1 - 25 of 44
Primary Open-angle Glaucoma, Ocular Hypertension Trial in Zagreb (Switching the preserved prostaglandin analog-timolol FC to
Recruiting
- Primary Open-angle Glaucoma
- Ocular Hypertension
- Switching the preserved prostaglandin analog-timolol FC to Fixalpost (preservative free prostaglandin analog-timolol FC)
-
Zagreb, CroatiaKlinički bolnički centar Zagreb
May 13, 2021
Opthalomology/Dry Eye Trial in Milan, Pisa (Afomill Refreshing Soothing, Afomill Anti-redness Eye Drops, Iridil)
Recruiting
- Opthalomology/Dry Eye
- Afomill Refreshing Soothing, Afomill Anti-redness Eye Drops, Iridil
-
Milan, Italy
- +1 more
Mar 17, 2023
Osgood-Schlatter Disease Trial in Aalborg (Tailored progressive loading and return to sport, Pain guided activity)
Recruiting
- Osgood-Schlatter Disease
- Tailored progressive loading and return to sport
- Pain guided activity
-
Aalborg, DenmarkResearch Unit for General Practice in Aalborg
Apr 21, 2023
Pregnancy Trial in Minneapolis (Occlusal Support Device, Control)
Completed
- Pregnancy
- Occlusal Support Device
- Control
-
Minneapolis, MinnesotaUniversity of Minnesota
Aug 25, 2022
Breath Test, Oesophageal Cancer, Gastric Cancer Trial in London (Oral Stimulant Drink)
Not yet recruiting
- Breath Test
- +4 more
- Oral Stimulant Drink
-
London, United KingdomVolatile Biomarker Group, Commonwealth Building, Hammersmith Hos
Oct 30, 2022
Ocular Surface Disease, Glaucoma Trial in Campobasso (Hydrocortisone (CORTIVIS ®))
Completed
- Ocular Surface Disease
- Glaucoma
- Hydrocortisone (CORTIVIS ®)
-
Campobasso, ItalyUniversity of Molise
Sep 30, 2021
Strip Meniscometry in Dry Eye Evaluation
Completed
- Dry Eye
- Dry Eye Disease
- Central visual acuity
- +9 more
-
Olomouc, CzechiaDepartment of Ophthalmology, University Hospital Olomouc
Nov 1, 2023
24 Month Follow-up of Patients With Osgood Schlatter (OSD)
Completed
- Osgood-Schlatter Disease
- Apophysitis
- Activity modification
-
Aalborg, DenmarkResearch Unit for General Practice in Aalborg
Jul 1, 2019
Hydrus Microstent as a Quality of Life Consideration
Recruiting
- Open Angle Glaucoma
- Hydrus Microstent
-
Fresno, CaliforniaTerri Smith
Jul 12, 2023
Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States
Recruiting
- Relapsed/Refractory B-cell Lymphomas
- +11 more
- CLBR001 and SWI019
-
Duarte, California
- +7 more
Jul 26, 2022
Glaucoma, Ocular Surface Disease Trial in Thessaloniki (Assessment of ocular surface staining (Oxford score 0-15 scale), mean
Completed
- Glaucoma
- Ocular Surface Disease
- Assessment of ocular surface staining (Oxford score 0-15 scale)
- mean diurnal intraocular pressure-lowering
-
Thessaloniki, GreeceUniversity Department of Ophthalmology
Dec 16, 2020
Dry Eye Disease, Dry Eye Syndrome, Evaporative Dry Eye Trial (The study will include three arms, one non interventional and 2
Not yet recruiting
- Dry Eye Disease
- +4 more
- The study will include three arms, one non interventional and 2 interventions. The intervention arms will include two commercially available sodium hyaluronate 0.1% (Systane ultra plus and Hylo-comod)
- (no location specified)
Jan 13, 2021
Chronic Ocular Graft-versus-host Disease Trial in Boston (Pro-ocular™ topical gel, Placebo topical gel)
Active, not recruiting
- Chronic Ocular Graft-versus-host Disease
- Pro-ocular™ topical gel
- Placebo topical gel
-
Boston, MassachusettsMassachusetts Eye and Ear Longwood
Mar 12, 2021
OssDsign® Spine Registry Study ("Propel")
Recruiting
- Degenerative Disc Disease
- Spinal Stenosis
- OssDsign® Catalyst
-
Paducah, Kentucky
- +1 more
Apr 29, 2022
Ocular Surface Disease Trial in East Kilbride (Autologous blood applied to dry eye)
Completed
- Ocular Surface Disease
- Autologous blood applied to dry eye
-
East Kilbride, Lanarkshire, United KingdomHairmyres Hospital
Apr 14, 2022
Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /
Completed
- Ocular Surface Disease
- Primary Open Angle Glaucoma
- Tafluprost, timolol maleate
-
Taoyuan city, TaiwanChang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022
Osteoarthritis, Hip, Blood Loss Trial (Werewolf Fastseal 6.0)
Not yet recruiting
- Osteoarthritis, Hip
- Blood Loss
- Werewolf Fastseal 6.0
- (no location specified)
Apr 26, 2022
Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Dorzolamide / Timolol Ophthalmic Solution
- dorzolamide/timolol
-
Olivos, Buenos Aires, Argentina
- +5 more
May 10, 2023
Ocular Surface Disease in Malaysian Glaucoma Patients
Unknown status
- Primary Open-angle Glaucoma
- +4 more
- (no location specified)
Oct 25, 2020
Glaucoma, Open-Angle, Ocular Hypertension Trial in Milano, Pavia, Roma (tafluprost/timolol)
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
-
Milano, Italy
- +2 more
Mar 18, 2022
Dry Eye Trial in Le Kremlin-Bicêtre (CBL-102 eye drops, Vismed Multi eye drops)
Completed
- Dry Eye
- CBL-102 eye drops
- Vismed Multi eye drops
-
Le Kremlin-Bicêtre, FranceHôpital Kremlin-Bicêtre
Oct 4, 2021
Intracranial Pressure Increase Trial in Konya (E-CUBE i7 ultrasound system (Alpinion Medical Systems, Seoul, Republic of Korea))
Not yet recruiting
- Intracranial Pressure Increase
- E-CUBE i7 ultrasound system (Alpinion Medical Systems, Seoul, Republic of Korea)
-
Konya, TurkeyUniversity of Health Science Konya City Hospital
Jan 5, 2023
Dry Eye Trial in Singapore (Rexon-eye)
Recruiting
- Dry Eye
- Rexon-eye
-
Singapore, SingaporeSingapore Eye Research Institute
Sep 21, 2021
Ocular Surface Disease, Dry Eye Syndromes Trial in Toronto (Autologous platelet rich plasma eye drops)
Unknown status
- Ocular Surface Disease
- Dry Eye Syndromes
- Autologous platelet rich plasma eye drops
-
Toronto, Ontario, CanadaToronto Western Hospital
Oct 22, 2020
Osgood-Schlatter Disease Trial in Basel (physiotherapy program, usual care treatment)
Recruiting
- Osgood-Schlatter Disease
- physiotherapy program
- usual care treatment
-
Basel, SwitzerlandDepartment of Sport, Exercise and Health, Medical Faculty Univer
Mar 3, 2022